套细胞淋巴瘤首次缓解时采用自体干细胞移植的大剂量疗法。
High-dose therapy with autologous stem cell transplantation in first response in mantle cell lymphoma.
作者信息
Vigouroux Stéphane, Gaillard Fanny, Moreau Philippe, Harousseau Jean-Luc, Milpied Noël
出版信息
Haematologica. 2005 Nov;90(11):1580-2.
PMID:16266909
Abstract
We retrospectively investigated the outcome of 30 newly diagnosed patients with mantle cell lymphoma treated with high-dose therapy and autologous stem cell transplantation in first response. With a median follow-up of 55 months, the 5-year overall-survival is 62%, the 5-year progression-free-survival is 40% and no secondary malignancy has occurred.
摘要
我们回顾性研究了30例初治时接受大剂量治疗及自体干细胞移植的新诊断套细胞淋巴瘤患者的预后情况。中位随访55个月，5年总生存率为62%，5年无进展生存率为40%，且未发生第二肿瘤。
Zotero 插件